Daniel D. Sternbach

Molecular Recognition of Fatty Acids by Peroxisome Proliferator–Activated Receptors

H. Eric Xu, Millard H. Lambert, Valerie G. Montana et al. · Molecular Cell · 1999 · 1.2K citations · Full text

Metabolic Syndrome, Lipid Synthesis, Biochemistry +1

A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport

William R. Oliver, Jennifer L. Shenk, Mike R. Snaith et al. · Proceedings of the National Academy of Sciences · 2001 · 1K citations · Full text

Molecular Pharmacology, Metabolic Syndrome, Insulin Signaling +15

Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)—synthesis and biological activity

Marcos L. Sznaidman, Curt D. Haffner, Patrick Maloney et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 311 citations · Full text

Biological Activity, Molecular Pharmacology, Biochemistry +11

Synthesis and Antitumor Activity of Novel Water Soluble Derivatives of Camptothecin as Specific Inhibitors of Topoisomerase I

Michael J. Luzzio, Jeffrey M. Besterman, David L. Emerson et al. · Journal of Medicinal Chemistry · 1995 · 145 citations · Full text

Specific Inhibitors, Medicinal Chemistry, Complex Enzyme Assay +14

Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library

Peter J. Brown, Tracey Smith-Oliver, Paul S. Charifson et al. · Chemistry & Biology · 1997 · 109 citations · Full text

Molecular Recognition, Medicinal Chemistry, Peroxisome Proliferator-activated Receptor +13